This Westminster Health Forum seminar will discuss the future of funding in the NHS, looking at priority areas, productivity and integration.
£32 million for antimicrobial resistance research
The Department of Health and Social Care will award up to £32 million of capital funding to the NHS, universities and research organisations for research into antimicrobial resistance (AMR).
Awarded through open competition by the National Institute for Health Research (NIHR), the funding will support capital investment in buildings and equipment to strengthen the UK’s AMR research capability in order to: develop innovative approaches to tackling AMR; establish a body of researchers with a wide range of skills and expertise relevant to AMR; and encourage external funding for AMR research.
Resistance to all antimicrobials, and especially bacterial resistance to existing antibiotics, is increasing. It is now posing a serious threat to health both in the UK and globally, and risks undermining the major improvements in medicine that have been made in recent decades.
Professor Dame Sally Davies, said: “Without dedicated efforts to combat antimicrobial resistance, modern medicine as we know it could be lost. Funding new and innovative approaches to tackle the problem is crucial, and this substantial capital funding will be a significant step towards strengthening UK-based AMR initiatives.”
Funding will be awarded for a two-year period starting on 1 April 2019. All funding provided to successful applicants must be spent by 31 March 2021.